Page 5 - ஓக்யாபி கூட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஓக்யாபி கூட்டாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஓக்யாபி கூட்டாளர்கள் Today - Breaking & Trending Today

Bonanza Creek Announces March 12, 2021 Special Meeting of Stockholders Relating to the Acquisition of HighPoint Resources


Share:
DENVER, Feb. 10, 2021 (GLOBE NEWSWIRE) Bonanza Creek Energy, Inc. (NYSE:BCEI) (the Company or Bonanza Creek ) today announced that a special meeting of stockholders of the Company (the Bonanza Creek special meeting ) is scheduled to take place on March 12, 2021 at 9:00 a.m., Mountain Time. The purpose of the Bonanza Creek special meeting is to approve the issuance of Bonanza Creek common stock to stockholders and noteholders of HighPoint Resources Corporation ( HighPoint ) in connection with the transaction pursuant to the Agreement and Plan of Merger, dated as of November 9, 2020, by and among the Company, HighPoint and Boron Merger Sub, Inc. (as amended from time to time, the merger agreement ). The record date for Bonanza Creek stockholders entitled to vote at the Bonanza Creek special meeting is the close of business on February 1, 2021. ....

Rocky Mountain , United States , New York , Weld County , Bonanza Creek , Scott Landreth , Boron Merger Sub Inc , Consent Solicitations The Exchange Prospectus , Highpoint Of The Exchange , Company Or Bonanza Creek , Highpoint Resources Corporation , Bonanza Creek Energy Inc , Company The Bonanza Creek , Highpoint Investor Relations Department , United States Bankruptcy Court , Exchange Commission , Bonanza Creek Investor Relations Department , Exchange Prospectus Or Registration , Exchange Prospectus , Securities Exchange , Creek Energy , Boron Merger Sub , Joint Proxy , United States Bankruptcy Code , Highpoint Senior Unsecured Notes , Exchange Offers ,

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger


Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
News provided by
Share this article
Share this article
ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 /PRNewswire/  Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ( Company, CBMG, we or our ), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that leading proxy advisory firms Glass, Lewis & Co. and Institutional Shareholder Services Inc. have both recommended that the Company s stockholders vote
FOR the proposal to adopt the definitive merger agreement that provides for the acquisition of CBMG for $19.75 in cash per share of common stock in a going private transaction (the merger proposal ).  ....

United States , Sarah Kelly , Exchange Commission On , Company Investor Contact , Lewis Co , Laboratory Of Cell Therapy , Company Definitive Proxy Statement On Schedule , Exchange Commission , Application Center , Securities Exchange , Cell Therapy Technology Innovation , Institutional Shareholder Services Inc , Cellular Biomedicine Group , Cellular Biomedicine Group Inc , Ge Healthcare , Institutional Shareholder Services , Center Drive , Definitive Proxy Statement , Okapi Partners , Biomedicine Group , Thermo Fisher , Knee Osteoarthritis , Loncar China Biopharma , Investor Relations , Private Securities Litigation Reform Act , Securities Act ,

Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares


Home / Top News / Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares
Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares
Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the proposed aggregate number of shares of common stock that the Company would be authorized to issue from 500,000,000 shares to 400,000,000 shares
MALVERN, Pa., Dec. 22, 2020 (GLOBE NEWSWIRE)
Ocugen, Inc
. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that it will convene its 2020 Annual Meeting of Stockholders on December 23, 2020 at 11:00 a.m. Eastern time and, after conducting all other business, intends to adjourn the meeting solely with respect to I ....

Sanjay Subramanian , Lisa Descenza , Exchange Commission On , Company Sixth , Certificate Of Organization , Ocugen Inc , Annual Meeting , Definitive Proxy Statement , Exchange Commission , Sixth Amended , Restated Certificate , Definitive Proxy , Okapi Partners , Private Securities Litigation Reform Act , சஞ்சய் சுப்ரமணியன் , லிசா சேசென்ச , பரிமாற்றம் தரகு ஆன் , நிறுவனம் ஆறாவது , சிஇஆர்டிஐஎஃப்ஐசிஏடிஇ ஆஃப் ஆர்கநைஸேஶந் , ஆண்டு சந்தித்தல் , உறுதியான ப்ராக்ஸி அறிக்கை , பரிமாற்றம் தரகு , உறுதியான ப்ராக்ஸி , ஓக்யாபி கூட்டாளர்கள் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,